Abstract | OBJECTIVE: The objective of this study was to determine the morbidity of preterm small for gestational age (SGA) infants compared with appropriate for GA (AGA). STUDY DESIGN: This is a secondary analysis of the randomized trial evaluating magnesium sulfate for the prevention of cerebral palsy (CP). We compared outcomes of preterm (< 37 weeks) nonanomalous infants who were SGA (birth weight < 10% for GA) versus AGA ( birth weight 10-89% for GA). We compared (1) the parent trial primary outcome, a composite of stillbirth, infant death by 1 year of age, or moderate to severe CP at 2 years of age and (2) composite neonatal morbidity (CNM). RESULTS: Of the 1,948 infants who met inclusion criteria, 95% were AGA and 5% were SGA. The primary outcome was similar (10 and 15%, p = 0.08), as was the CNM (24 and 25%, p = 0.89). Sample size calculations indicate that detection of a one-third higher rate of CNM among SGA compared with AGA infants requires more than 93,900 preterm births; for a one-third difference in moderate to severe CP, more than 1.4 million infants. CONCLUSION: Owing to the prohibitive sample size required, ascertaining a difference in sequela between preterm SGA and AGA infants is possibly unverifiable.
|
Authors | Caroline C Marrs, Hector Mendez-Figueroa, Ibrahim A Hammad, Suneet P Chauhan |
Journal | American journal of perinatology
(Am J Perinatol)
Vol. 32
Issue 13
Pg. 1251-6
(Nov 2015)
ISSN: 1098-8785 [Electronic] United States |
PMID | 26023905
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Copyright | Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA. |
Chemical References |
- Calcium Channel Blockers
- Magnesium Sulfate
|
Topics |
- Calcium Channel Blockers
(therapeutic use)
- Case-Control Studies
- Cerebral Palsy
(epidemiology, prevention & control)
- Double-Blind Method
- Female
- Fetal Growth Retardation
(epidemiology)
- Humans
- Infant, Extremely Premature
- Infant, Newborn
- Infant, Premature
- Infant, Small for Gestational Age
- Magnesium Sulfate
(therapeutic use)
- Multivariate Analysis
- Perinatal Care
- Pregnancy
- Regression Analysis
- Treatment Outcome
|